On April 1, 2024 aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, reported that the company will participate in two upcoming investor conferences scheduled to take place in April 2024 (Press release, aTyr Pharma, APR 1, 2024, View Source [SID1234641673]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the conferences appear below:

Conference: Evercore ISI Diamonds in the Rough Webinar Day
Date: Thursday, April 4, 2024
Time: 10:30am EDT
Location: Virtual
Format: Corporate Presentation with Q&A Session

Conference: Piper Sandler Spring Biopharma Symposium
Date: Wednesday, April 17, 2024
Location: Everett, MA
Format: 1×1 Investor Meetings

For more information on how to register, please contact your Evercore ISI or Piper Sandler representative.